Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
25/06/2026 05:33
BRIEF-Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility June 25 (Reuters) - Concord Biotech Ltd CONB.NS:
CONCORD BIOTECH - COMPLETES PPB (KENYA) AND NDA (UGANDA) INSPECTION AT UNIT-II FORMULATION FACILITY
Source text: ID:nBSE7xbDYz
Further company coverage: CONB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval